Skip to content

Homoeopathy in swollen tonsils

Effectiveness of individualized homoeopathic medicines based on synthesis repertory in cases of adenoids: An open label prospective, clinical study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064654
Enrollment
40
Registered
2024-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J352- Hypertrophy of adenoids

Interventions

Intervention1: Individualized Homoeopathic medicine: Indicated individualized homoeopathic medicine will be prescribed after the repertorisation of the case using rubrics within synthesis repertory. D

Sponsors

National Institute of Homeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of all sexes, in the age group of 1-17 years with normal hearing status. 2.Patients attending NIH, Kolkata outpatient or inpatient ward who are suffering from enlarged adenoids or strong clinical diagnosed features of adenoid hypertrophy. 3.Patients’ parents willing to give written informed consent and the patients willing to give verbal assent (children aged between 6-11years) and or written assent (children aged between 12-17years. 4.Patients willing to do all necessary laboratory tests as required.

Exclusion criteria

Exclusion criteria: 1.Complicated cases of adenoids, cleft lip, unilateral or bilateral nasal polypi. 2.Critically ill patients, immuno-compromised patients, other fatal systemic diseases, unstable mental or psychiatric illnesses. 3.Patients already undergoing conventional treatment for adenoids. 4.Patients with history of adenoidectomy or cleft palate. 5.Patients with substance abuse.

Design outcomes

Primary

MeasureTime frame
Symptoms Grading ScoreTimepoint: Baseline and 6 months

Secondary

MeasureTime frame
Modified Naranjo Criteria For Homoeopathy (MONARCH)Timepoint: At the end of treatment (6month)

Countries

India

Contacts

Public ContactProf. (Dr.) Avijit Shee Burman

National Institute of Homoeopathy

asheeburman@gmail.com9433392108

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026